Ulisse Biomed S.p.A. (BIT:UBM)

Ulisse Biomed Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24	17	36	8	24	-
Market Cap Growth	16.73%	-52.90%	334.87%	-65.95%	-	-
Enterprise Value	24	16	33	4	24	-
Last Close Price	1.00	0.76	1.66	1.02	3.33	-
PS Ratio	26.44	21.90	539.18	59.30	85.96	-
PB Ratio	1.15	0.71	1.31	1.38	3.32	-
P/TBV Ratio	8.33	4.04	6.71	1.63	3.80	-
EV/Sales Ratio	26.38	20.87	495.44	27.28	85.25	-
Debt / Equity Ratio	0.05	0.01	0.02	0.00	0	0
Debt / EBITDA Ratio	-	-	-	-	-	0.00
Asset Turnover	0.04	0.03	0.00	0.02	0.06	0.36
Inventory Turnover	0.91	0.98	1.53	9.48	6.96	4.02
Quick Ratio	1.51	1.60	1.26	11.72	16.82	2.75
Current Ratio	2.53	2.44	1.75	12.03	17.06	2.98
Return on Equity (ROE)	-23.06%	-23.28%	-28.81%	-19.81%	-13.70%	19.92%
Return on Assets (ROA)	-12.80%	-13.05%	-15.69%	-12.10%	-7.63%	8.21%
Return on Capital (ROIC)	-14.48%	-14.93%	-17.93%	-13.37%	-8.56%	12.57%
Return on Capital Employed (ROCE)	-	-	-	-	-	14.30%
Earnings Yield	-21.66%	-35.33%	-13.44%	-15.93%	-2.50%	-
FCF Yield	-10.88%	-21.18%	-2.73%	-12.78%	-1.64%	-
Payout Ratio	-	-	-	-	-	9.34%
Buyback Yield / Dilution	-12.28%	-13.50%	-167.46%	-0.01%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.